Prognosis of morbid obesity patients with advanced heart failure

Vijaiganesh Nagarajan1, Clay A Cauthen, Randall C Starling

  • 1Department of Hospital Medicine, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Insights

The obesity paradox may not apply to morbidly obese patients with advanced heart failure. Morbid obesity is linked to a higher risk of mortality and transplantation, challenging previous findings.

Area of Science:

  • Cardiology
  • Obesity Medicine

Background:

  • The obesity paradox suggests better outcomes for obese patients in certain conditions, including heart failure.
  • This study investigates whether this paradox holds true for individuals with morbid obesity and advanced heart failure.

Purpose of the Study:

  • To examine the relationship between body mass index (BMI) categories and prognosis in patients with advanced heart failure.
  • To determine if morbid obesity (BMI ≥40 kg/m²) is associated with worse outcomes compared to obesity (BMI 30.1-40 kg/m²) and non-obesity (BMI ≤30 kg/m²).

Main Methods:

  • A cohort of 501 consecutive patients with advanced heart failure undergoing heart transplant evaluation was analyzed.
  • Patients were stratified into three BMI groups: nonobese, obese, and morbidly obese.
  • Survival rates and risk of all-cause mortality/transplantation were compared across groups using univariate and multivariate analyses.

Main Results:

  • Unadjusted event-free survival rates were significantly lower in the morbidly obese group (28.6%) compared to obese (57.4%) and nonobese (48.4%) groups.
  • Both nonobese and morbidly obese patients faced a significantly higher risk of mortality/transplantation compared to the obese group, even after adjusting for confounding factors.
  • The morbidly obese group exhibited fewer cardiovascular risk factors, suggesting these factors may not explain the observed survival differences.

Conclusions:

  • The obesity paradox is present in advanced heart failure but does not extend to morbidly obese patients.
  • Morbid obesity is associated with a poorer prognosis in advanced heart failure, independent of traditional cardiovascular risk factors.
  • Clinical management strategies for advanced heart failure should consider the distinct risks associated with morbid obesity.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...